DAVID POPLACK to Central Nervous System Diseases
This is a "connection" page, showing publications DAVID POPLACK has written about Central Nervous System Diseases.
Connection Strength
0.480
-
Central nervous system leukemia. Curr Opin Oncol. 1996 Jan; 8(1):13-9.
Score: 0.119
-
Current pharmacological treatment approaches to central nervous system leukaemia. Drugs. 1991 May; 41(5):702-16.
Score: 0.086
-
Late CNS sequelae in long term survivors of childhood leukemia. An Esp Pediatr. 1988 Oct; 29 Suppl 34:19-26.
Score: 0.072
-
Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J Infect Dis. 1988 Jan; 157(1):178-80.
Score: 0.068
-
Experimental approaches to the treatment of CNS leukemia. Am J Pediatr Hematol Oncol. 1979; 1(2):141-9.
Score: 0.037
-
Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoir. Med Pediatr Oncol. 1979; 6(3):207-13.
Score: 0.037
-
Hypothalamic-pituitary dysfunction following CNS prophylaxis in acute lymphocytic leukemia: correlation with CT scan abnormalities. Med Pediatr Oncol. 1979; 7(2):141-51.
Score: 0.037
-
Complications of leukemia. Pediatr Rev. 1991 Apr; 12(10):313-8.
Score: 0.021
-
Neurotoxicities of current leukemia therapy. Am J Pediatr Hematol Oncol. 1979; 1(2):127-40.
Score: 0.002
-
Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep. 1978 Dec; 62(12):2031-4.
Score: 0.002